{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:26:33Z","timestamp":1792207593881,"version":"4.4.0"},"reference-count":21,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,10,12]]},"DOI":"10.1182\/blood-2017-07-795302","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T21:00:31Z","timestamp":1502485231000},"page":"1772-1774","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":76,"title":["Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma"],"prefix":"10.1182","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4652-4825","authenticated-orcid":false,"given":"Antonio","family":"Salar","sequence":"first","affiliation":[{"name":"Department of Hematology, Hospital del Mar, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Domingo-Domenech","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Durans i Reynals, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Panizo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Cl\u00ednica Universitaria de Navarra, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Nicol\u00e1s","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Central de Asturias, Asturias, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Bargay","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Son Llatzer, Mallorca, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Munta\u00f1ola","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario Mutua de Terrassa, Terrassa, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Canales","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario La Paz, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Bello","sequence":"additional","affiliation":[{"name":"Department of Hematology, Complejo Universitario de Santiago, Santiago de Compostela, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Sancho","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Germans Trias i Pujol, Badalona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Francisco","family":"Tom\u00e1s","sequence":"additional","affiliation":[{"name":"Department of Hematology, MD Anderson Cancer Center, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario de Canarias, Tenerife, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pe\u00f1alver","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Fundaci\u00f3n Alcorc\u00f3n, Alcorc\u00f3n, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Grande","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Javier","family":"S\u00e1nchez-Blanco","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Morales Meseguer, Murcia, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Palomera","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Cl\u00ednico Lozano Blesa, Zaragoza, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyes","family":"Arranz","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario La Princesa, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulogio","family":"Conde","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Marqu\u00e9s de Valdecilla, Santander, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Hospital Universitario Miguel Servet, Zaragoza, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Fernando","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, MD Anderson Cancer Center, Madrid, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Caballero","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Cl\u00ednico de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Montalb\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Hematology, MD Anderson Cancer Center, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2019111903175932300_B1","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1997.15.4.1624","article-title":"Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients","volume":"15","author":"Thieblemont","year":"1997","journal-title":"J Clin Oncol"},{"issue":"22","key":"2019111903175932300_B2","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","article-title":"Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome","volume":"21","author":"Tsang","year":"2003","journal-title":"J Clin Oncol"},{"issue":"8871","key":"2019111903175932300_B3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","article-title":"Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori","volume":"342","author":"Wotherspoon","year":"1993","journal-title":"Lancet"},{"issue":"24","key":"2019111903175932300_B4","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.2011.41.4466","article-title":"Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial","volume":"30","author":"Ferreri","year":"2012","journal-title":"J Clin Oncol"},{"issue":"10","key":"2019111903175932300_B5","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1200\/JCO.1995.13.10.2524","article-title":"Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression","volume":"13","author":"Hammel","year":"1995","journal-title":"J Clin Oncol"},{"issue":"10","key":"2019111903175932300_B6","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/cncr.20237","article-title":"Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma","volume":"100","author":"Zinzani","year":"2004","journal-title":"Cancer"},{"issue":"8","key":"2019111903175932300_B7","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type","volume":"102","author":"Conconi","year":"2003","journal-title":"Blood"},{"issue":"9","key":"2019111903175932300_B8","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","article-title":"Clinical activity of rituximab in gastric marginal zone non-Hodgkin\u2019s lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy","volume":"23","author":"Martinelli","year":"2005","journal-title":"J Clin Oncol"},{"issue":"9","key":"2019111903175932300_B9","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1158\/1078-0432.CCR-04-2282","article-title":"High relapse rate in patients with MALT lymphoma warrants lifelong follow-up","volume":"11","author":"Raderer","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2019111903175932300_B10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3324\/haematol.11835","article-title":"Dissemination patterns in non-gastric MALT lymphoma","volume":"93","author":"de Boer","year":"2008","journal-title":"Haematologica"},{"issue":"2","key":"2019111903175932300_B11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3322\/caac.21330","article-title":"Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)","volume":"66","author":"Raderer","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"22","key":"2019111903175932300_B12","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1002\/cncr.24605","article-title":"Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type","volume":"115","author":"Salar","year":"2009","journal-title":"Cancer"},{"issue":"5","key":"2019111903175932300_B13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1200\/JCO.2011.40.6272","article-title":"Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 randomized study","volume":"31","author":"Zucca","year":"2013","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019111903175932300_B14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood-2016-06-720599","article-title":"A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma","volume":"129","author":"Kiesewetter","year":"2017","journal-title":"Blood"},{"issue":"3","key":"2019111903175932300_B15","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1016\/S2352-3026(14)00021-0","article-title":"First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial","volume":"1","author":"Salar","year":"2014","journal-title":"Lancet Haematol"},{"issue":"4","key":"2019111903175932300_B16","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"2019111903175932300_B17","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events version 3.0, 2006. Available at: http:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcaev3.pdf. Accessed 17 November 2008."},{"issue":"17","key":"2019111903175932300_B18","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1200\/JCO.2016.70.6994","article-title":"Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy","volume":"35","author":"Zucca","year":"2017","journal-title":"J Clin Oncol"},{"issue":"22","key":"2019111903175932300_B19","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2005.05.660","article-title":"Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy","volume":"23","author":"L\u00e9vy","year":"2005","journal-title":"J Clin Oncol"},{"issue":"29","key":"2019111903175932300_B20","doi-asserted-by":"crossref","first-page":"7361","DOI":"10.1200\/JCO.2005.02.6138","article-title":"Persistent residual disease in t(11;18)(q21;q21) positive gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy or rituximab","volume":"23","author":"Salar","year":"2005","journal-title":"J Clin Oncol"},{"key":"2019111903175932300_B21","article-title":"A MALT lymphoma prognostic index generated from the dataset of the IELSG-19 prospective clinical trial [published online ahead of print 18 July 2017]","volume-title":"Blood","author":"Thieblemont"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/15\/1772\/1403094\/blood795302.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/15\/1772\/1403094\/blood795302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:18:11Z","timestamp":1574133491000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/130\/15\/1772\/36392\/Longterm-results-of-a-phase-2-study-of-rituximab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,12]]},"references-count":21,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017,10,12]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-07-795302","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,12]]}}}